NCT01095029

Brief Summary

The purpose of this study is to determine whether Sacral Nerve Stimulation (SNS) for idiopathic faecal incontinence affect cortical and deep brain activity in an acute and chronically stimulation model. Furthermore the association between brain activity and unilateral/bilateral SNS will be studied in each patient. Brain activity will be studied by use of positron emission tomography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 29, 2010

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

July 4, 2014

Status Verified

March 1, 2012

Enrollment Period

2.5 years

First QC Date

March 22, 2010

Last Update Submit

July 3, 2014

Conditions

Keywords

Positron emission tomography (PET)Idiopathic Faecal IncontinenceBilateral Sacral Nerve StimulationSacral Nerve StimulationSacral Nervemodulation

Outcome Measures

Primary Outcomes (1)

  • Changes in Regional Cerebral Blood Flow with different pacemaker settings

    RCBF evaluated with positron emission tomography.

    12 weeks after study enrolment

Secondary Outcomes (1)

  • Changes in continence and quality of life with different pacemaker activation.

    12 weeks after study enrolment

Study Arms (3)

Off/Off

EXPERIMENTAL

Pacemaker status: Bilateral Off for four weeks before first PET scann.

Device: Medtronic InterStim II - 3058

On/On

EXPERIMENTAL

Pacemaker status: Bilateral On. PET scan one hour after activation and after four weeks continuous stimulation.

Device: Medtronic InterStim II - 3058

On/Off

EXPERIMENTAL

Pacemaker status: Unilateral On. PET scan one hour after activation and after four weeks continuous stimulation.

Device: Medtronic InterStim II - 3058

Interventions

Stimulation with optimal pacemaker settings unilateral and bilateral with standard pacemaker settings: Amplitude sensory treshold, frequency 14 Hz and impulsduration 210 μsec.

Off/OffOn/OffOn/On

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Informed consent
  • Idiopathic fecal incontinence or Fecal incontinence due to small sphincter defect(≤60 o)
  • Permanent neuromodulator (medtronic InterStim II) bilateral implanted
  • Reduction in fecal incontinence episodes of at least 50% between baseline and latest follow up with unilateral stimulation(Bowel diary card)
  • Willing and competent to fill out diary cards
  • MR-cerebrum before implantatation of neuromodulator
  • Right-handed dominant

You may not qualify if:

  • Colorectal/proctological surgery since IPG-implant
  • Pregnancy
  • Neurological diseases including spinal cord injury.
  • Use of medication with known alternation of gastrointestinal motilitet (thyroid, diabetes, neuroleptica)
  • Claustrofobia
  • Latex allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anal Physiology Laboratory, Surgical Research Section 900, Aarhus University Hospital

Aarhus, Aarhus C, 8000, Denmark

Location

MeSH Terms

Conditions

Fecal Incontinence

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Jakob K Jakobsen, MD.

    Anal Physiology Laboratory, Surgical Research Section 900, Aarhus University Hospital, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2010

First Posted

March 29, 2010

Study Start

February 1, 2010

Primary Completion

August 1, 2012

Study Completion

July 1, 2014

Last Updated

July 4, 2014

Record last verified: 2012-03

Locations